Hem Pharma Inc.
Pohang-si, KR· latest recorded location
HEM PHARMA INC. is named on 5 US grants and 17 published applications in this corpus. Its most frequent classification is G16H (Healthcare informatics, i.e. information and communication technology [ict] specially adapted for the).
- Granted patents
- 5
- Published applications
- 17
- Inventors
- 10
- Granted in 2026 so far
- 1
- Most recent grant
- 20 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2023 | 0 | 10 |
| 2024 | 0 | 3 |
| 2025 | 4 | 2 |
| 2026 | 1 | 2 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 22 documents
- G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the12
- G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or9
- C12NMicroorganisms or enzymes8
- G06NAI and machine learning8
- A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for7
- A61KMedicines and medical preparations7
- A61PTherapeutic uses of medicines7
- C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms6
- G01NInvestigating or analysing materials by determining their chemical or physical properties6
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms5
Recent patents
- Strain of Bifidobacterium animalis subsp. lactis HEM20-01 and composition for treating depression, comprising the same or its culture fluid20 Jan 2026US 12,527,824 B2
- Method and diagnostic apparatus for determining enteritis using machine learning model9 Dec 2025US 12,494,289 B2
- Method and diagnostic apparatus for determining constipation using machine learning model21 Oct 2025US 12,451,254 B2
- Strain of Lactobacillus sakei HEM224, and composition for treating inflammation or asthma comprising strain or cultured product thereof30 Sep 2025US 12,428,620 B2
- Method for screening personalized intestinal environment-improving material and composition therefor22 Apr 2025US 12,282,026 B2
- Fecal gas time curve analysis method for bristol stool type classification26 Mar 2026US 2026/0086076 A1
- Fecal gas component ratio analysis method for bristol stool type classification26 Mar 2026US 2026/0086077 A1
- Composition for ameliorating side effects caused by cancer treatment comprising lactobacillus fermentum hem1036 strain as active ingredient3 Jul 2025US 2025/0213632 A1
- Novel bifidobacterium bifidum hem972 strain, and composition for improving intestinal environment, comprising same strain or culture of same6 Feb 2025US 2025/0041360 A1
- Method and diagnostic apparatus for determining enteric disorder using machine learning model21 Mar 2024US 2024/0096496 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.